LHC Group (LHCG) Receives $76.11 Consensus Target Price from Brokerages

LHC Group (NASDAQ:LHCG) has earned an average recommendation of “Buy” from the eleven brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $76.11.

LHCG has been the topic of several analyst reports. Royal Bank Of Canada restated a “buy” rating and set a $69.00 price objective on shares of LHC Group in a report on Tuesday, July 18th. Craig Hallum restated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Bank of America Corporation initiated coverage on LHC Group in a report on Monday, August 21st. They set a “buy” rating and a $76.00 price objective on the stock. BidaskClub upgraded LHC Group from a “hold” rating to a “buy” rating in a report on Friday, August 18th. Finally, Jefferies Group LLC restated a “buy” rating and set a $68.00 price objective on shares of LHC Group in a report on Friday, August 4th.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the transaction, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 14.80% of the company’s stock.

Several institutional investors have recently made changes to their positions in LHCG. BlackRock Inc. grew its stake in shares of LHC Group by 43,223.7% during the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after acquiring an additional 1,964,950 shares in the last quarter. Royal Bank of Canada grew its stake in shares of LHC Group by 50,943.5% during the second quarter. Royal Bank of Canada now owns 165,381 shares of the health services provider’s stock valued at $11,229,000 after acquiring an additional 165,057 shares in the last quarter. Castleark Management LLC acquired a new stake in shares of LHC Group during the second quarter valued at about $7,661,000. AJO LP acquired a new stake in shares of LHC Group during the second quarter valued at about $6,300,000. Finally, Robeco Institutional Asset Management B.V. acquired a new stake in shares of LHC Group during the third quarter valued at about $5,197,000. Institutional investors own 87.29% of the company’s stock.

WARNING: “LHC Group (LHCG) Receives $76.11 Consensus Target Price from Brokerages” was originally reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.truebluetribune.com/2017/11/15/lhc-group-lhcg-receives-76-11-consensus-target-price-from-brokerages.html.

LHC Group (NASDAQ:LHCG) traded up $0.97 during mid-day trading on Friday, hitting $68.78. The stock had a trading volume of 113,500 shares, compared to its average volume of 136,627. LHC Group has a 1-year low of $41.66 and a 1-year high of $76.14. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $1,239.54, a PE ratio of 29.10, a price-to-earnings-growth ratio of 2.01 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.04. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business had revenue of $272.90 million for the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter last year, the firm earned $0.54 earnings per share. The business’s revenue was up 18.2% on a year-over-year basis. sell-side analysts forecast that LHC Group will post 2.4 EPS for the current year.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply